To prevent acute kidney injury, the patient was prohibited from taking oral ACE-I when he was not well, such as if he had a fever, cold, other infectious diseases, etc. In his clinical course, the combination therapy of AST-120 and ACE-I was effective for his refractory periodic vomiting and hypertension associated with CKD (Fig. 1). This evidence concerns the gene ACE and acute kidney injury.